Atlas Trials

Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers

Clinical trial NCT02652754 · COMPLETED

Trial details

NCT number
NCT02652754
Sponsor
Xequel Bio, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetic Foot Ulcers
Start date
2015-09-01
Primary completion
2017-12-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.